The future
of glucose
monitoring is
in the breath
Our breath says a lot about our health.
We just need to know how to read it.
Diabetonic can do this.
In a single breath, we exhale more than 500 different compounds. The concentration of some of them reveals what is happening in the body and can indicate specific diseases.
Compounds such as acetone, ethanol, methanol, ethylbenzene, and isoprene are diabetes biomarkers. Their concentration in the exhaled air is linked to blood glucose level.
Diabetonic measures the concentration of diabetes biomarkers in the breath and determines the glucose level in the blood based on the algorithm.
References:
International recognition in
the scientific world
12 patents
30 international science awards
Gold medal and special award by the World WIIPA Federation President
The best discovery under the Invention and Design Competition IIDC-2017 Award
2nd place at the 20th Interventional Cardiology Workshop – New Frontiers in International Cardiology
INNOVATIVE SENSOR SYSTEM
Resistant, semiconductor gas sensors designed especially for medical use.
ACCURACY IN ACCORDANCE WITH THE EN ISO 15197:2015 STANDARD*
A precise medical device, which ensures repeatability and meets the European standards.
* undergoing certification
ARTIFICIAL INTELLIGENCE ALGORITHM
The key algorithm (AI/ML) identifies diabetes biomarkers contained in exhaled air and compares them with the calibration curve.
INDIVIDUAL CALIBRATION
Results are compared with results obtained by the traditional method of measurement, e.g. a glucometer.
A respite
for diabetics worldwide
International recognition in the scientific community
Relief for parents
We want children to enjoy their childhood without the continuous continual stress associated with pricking.
*minimum usage age shall be determined during clinical trials
Ease for
seniors
Choosing a prick point after years of using a glucometer is a challenge. Diabetonic allows you to forget about this matter.
Support for care systems
Expansion of a telemedical module integrated with monitoring systems for patients requiring continuous care.
Screening tests improvement
Faster, cheaper and simpler logistically. Early detection means a better future for the diabetes patients.
Stationary version
We are currently working on formalities to bring a stationary version for hospitals and clinics to the market.
